Target intelligence / Profile preview

Elongin C pseudogene 22 (ELOCP22)

Target: ELOCP22
Molecular classification: Other (pseudogene)

Overview

Elongin C pseudogene 22 is a non-protein-coding pseudogene in the human genome, annotated as a sequence related to the ELOC gene. Unlike the canonical elongin C, which is a component of the transcription factor B (SIII) complex involved in transcriptional regulation and ubiquitin ligase activity, this pseudogene does not produce a functional protein and is not implicated in therapeutic targeting, disease, or drug interaction[2].

Other names: TCEB1P22transcription elongation factor B (SIII), polypeptide 1 pseudogene 22transcription elongation factor B subunit 1 pseudogene 22ELOCP22

Beyond the preview

Go deeper on Elongin C pseudogene 22 (ELOCP22).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elongin C pseudogene 22 (ELOCP22).

Explore the full profile